首页> 外文期刊>Urology >In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
【24h】

In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.

机译:钙磷蛋白C作为膀胱癌光动力治疗的新型药物的体外评估。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: Calphostin C, a highly specific protein kinase C inhibitor, induces apoptosis in the presence of visible light. We report the photoactivatable cytotoxicity of calphostin C in a series of well-characterized human bladder cancer cell lines: RT4, UM-UC-3, and 5637. METHODS: The human bladder cancer cell lines RT4, UM-UC-3, and 5637 were chosen on the basis of their p53, pRb and 9p21 deletion status. Using standard tissue culture techniques, the cytotoxicity of 10 to 100 nM calphostin C in combination with increasing exposures of visible light was examined. Controls consisted of cells treated with calphostin C without visible light and cells exposed to visible light without calphostin C treatment. Cell viability was determined by MTT assay. The induction of apoptosis by activated calphostin C was determined by 4,6-diamidino-2-phenylindole (DAPI) staining/fluorescence microscopy of nuclei. RESULTS: In the absence of light, calphostin C did not demonstrate a cytotoxic effect on any of the cell lines tested. Increasing the duration of light exposure resulted in a concomitant decrease in cell viability. Significant cell death was seen with calphostin C concentrations as low as 10 nM. These studies also demonstrated that calphostin C induced apoptosis by a mechanism independent of p53 and pRb status and the presence or absence of 9p21 deletions. CONCLUSIONS: We demonstrated the ability of activated calphostin C to induce apoptosis in a light-dependent and concentration-dependent fashion in a bladder cancer model system. Activated calphostin C cytotoxicity is independent of tumor genetic background and the status of p53 and pRb. Further development of calphostin C as a photosensitizer for photodynamic therapy of superficial bladder cancer may be warranted.
机译:目的:钙磷蛋白C,一种高度特异性的蛋白激酶C抑制剂,在可见光存在下诱导细胞凋亡。我们报告钙磷蛋白C在一系列特征明确的人膀胱癌细胞系:RT4,UM-UC-3和5637中的光活化细胞毒性。方法:人膀胱癌细胞系RT4,UM-UC-3和5637根据它们的p53,pRb和9p21缺失状态选择它们。使用标准的组织培养技术,研究了10至100 nM钙磷蛋白C与可见光暴露量增加的细胞毒性。对照组由未经钙光钙蛋白C处理的细胞和未经钙磷蛋白C处理的细胞暴露于可见光组成。通过MTT测定法测定细胞活力。通过核的4,6-二mid基-2-苯基吲哚(DAPI)染色/荧光显微镜检查确定了活化钙磷蛋白C诱导的凋亡。结果:在没有光照的情况下,钙磷蛋白C对任何测试的细胞系均未显示出细胞毒性作用。增加曝光时间会导致细胞活力随之下降。钙磷蛋白C浓度低至10 nM,可见大量细胞死亡。这些研究还证明钙磷蛋白C通过不依赖于p53和pRb状态以及是否存在9p21缺失的机制来诱导凋亡。结论:我们证明了活化的钙磷蛋白C在膀胱癌模型系统中以光依赖性和浓度依赖性方式诱导凋亡的能力。活化的钙磷蛋白C的细胞毒性与肿瘤的遗传背景以及p53和pRb的状态无关。钙磷蛋白C作为用于光动力疗法治疗浅表性膀胱癌的光敏剂有待进一步开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号